Carcinoma of the Prostate

Oncology

11 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Approved(2)

Drug	Company
bicalutamide	SUNSET ISLAND GROUP (SUN)
bicalutamide	Aptinyx Inc. (APTX)

Phase 3(4)

Phase 2(2)

Drug	Company
Antiandrogen Therapy	Royalty Pharma plc (RPRX)
triptorelin	KYNTRA BIO INC. (KYNB)

Phase 1(1)

Drug	Company
Androgen Deprivation Therapy	Janux Therapeutics, Inc. (JANX)

Phase 4(2)

Drug	Company
Androgen Deprivation Therapy	Royalty Pharma plc (RPRX)
Androgen-deprivation Therapy	Royalty Pharma plc (RPRX)

BioSniper tracks 11 drugs in development for Carcinoma of the Prostate across 5 companies.

There are 1 clinical trial targeting Carcinoma of the Prostate tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.